These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1784261)

  • 1. [Cytokines in chronic polyarthritis. Pathogenesis and new principles of therapy].
    Wasielewski S
    Med Monatsschr Pharm; 1991 Dec; 14(12):354-5. PubMed ID: 1784261
    [No Abstract]   [Full Text] [Related]  

  • 2. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis.
    van den Berg WB
    Z Rheumatol; 1999 Jun; 58(3):136-41. PubMed ID: 10441840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of rheumatoid arthritis: targeting cytokines.
    Zwerina J; Redlich K; Schett G; Smolen JS
    Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
    Brennan FM; Cope AP; Katsikis P; Gibbons DL; Maini RN; Feldmann M
    Chem Immunol; 1995; 60():48-60. PubMed ID: 7857528
    [No Abstract]   [Full Text] [Related]  

  • 6. [Initial clinical experiences in the treatment of chronic polyarthritis with a new monokine release inhibitor].
    Seibel MJ; Brückle W; Respondek M; Beveridge T; Schnyder J; Müller W
    Z Rheumatol; 1989; 48(3):147-51. PubMed ID: 2675492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New inflammatory mediators and therapeutic agents: cytokines in rheumatoid arthritis.
    Tan PL; Skinner MA; Grinlinton FM
    N Z Med J; 1992 Nov; 105(945):447-9. PubMed ID: 1436857
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental therapy of rheumatoid arthritis with cytokine antagonists].
    Manger B
    Z Rheumatol; 1995; 54(2):105-9. PubMed ID: 7793156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["There are still differences between non-steroidal anti-rheumatic drugs". G. L. Bach, Bayreuth, elaborates on the clinical significance of interleukin 1 inhibition].
    Bach GL
    Fortschr Med; 1989 Mar; 107(7):71-2. PubMed ID: 2785077
    [No Abstract]   [Full Text] [Related]  

  • 12. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines in rheumatoid arthritis. II. Anti-inflammatory cytokines].
    Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2001 Dec; 11(66):514-6. PubMed ID: 11899851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine regulation of chondrocyte functions.
    Lotz M; Blanco FJ; von Kempis J; Dudler J; Maier R; Villiger PM; Geng Y
    J Rheumatol Suppl; 1995 Feb; 43():104-8. PubMed ID: 7752111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokines and anti-cytokines in inflammatory rheumatism].
    Dayer JM
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):173S-180S. PubMed ID: 7858569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
    J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts.
    Scott BB; Zaratin PF; Colombo A; Hansbury MJ; Winkler JD; Jackson JR
    J Rheumatol; 2002 Feb; 29(2):230-9. PubMed ID: 11838839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acid coxibs, NO donors, cytokine inhibitors. New beginnings against rheumatism].
    MMW Fortschr Med; 2002 Nov; 144(48):62. PubMed ID: 12532552
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor alpha.
    Dayer JM
    J Rheumatol Suppl; 1991 Feb; 27():71-5. PubMed ID: 2027136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.